Insight Wealth Strategies’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
NAM
GI
VCM
FFA
CA
FFO
TC
GWM
DCM
Insight Wealth Strategies's ASTH Position: Q3 2026 in Review
Insight Wealth Strategies reduced its Astrana Health (ASTH) stake by 2.5% in Q3 2026, selling an estimated $143K and leaving 139,664 shares worth $4.97M. The position accounts for 0.49% of the portfolio, ranked #67.
Insight Wealth Strategies first reported a position in ASTH in Q4 2025 and has held it in 4 quarters since. The position peaked at $7.14M in Q2 2026. 11 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.
- Insight Wealth Strategies held 139,664 shares of Astrana Health worth $4.97M as of Q3 2026.
- Insight Wealth Strategies sold 3,625 Astrana Health shares in Q3 2026, an estimated $143K.
- Astrana Health made up 0.49% of Insight Wealth Strategies's portfolio in Q3 2026, its #67 holding.
- Insight Wealth Strategies first reported a position in Astrana Health in Q4 2025 and has held it in 4 quarters since.
- Insight Wealth Strategies's Astrana Health position peaked at $7.14M in Q2 2026.
- 11 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.
Based on Insight Wealth Strategies's 13F filing for Q3 2026, filed 9 Oct 2026.